THURSDAY, June 16, 2022 (HealthDay News) — Treating precancerous anal growths in people with HIV slashes their risk of anal cancer by more than half, according to a new study. Researchers found that treating these growths — called high-grade squamous intraepithelial lesions (HSIL) — is a safe and effective wayContinue Reading
WEDNESDAY, June 15, 2022 (HealthDay News) — Cancer clinical trials in the United States appear to be rebounding after a significant slowdown during the pandemic, researchers say. For the study, the investigators analyzed data from the Dana-Farber Cancer Institute in Boston and the Tisch Cancer Institute at Mount Sinai MedicalContinue Reading
MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading
FRIDAY, June 10, 2022 (HealthDay News) — A requirement for all international travelers flying to the United States to take a COVID-19 test within a day of departure will be lifted on Sunday, a senior Biden administration official said Friday. The U.S. Centers for Disease Control and Prevention has determinedContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — A blood test could save some colon cancer patients from getting unnecessary chemotherapy following surgery, while making sure that those who would benefit from the treatment get it, researchers report. The circulating tumor DNA (ctDNA) test looks for minute amounts of genetic materialContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — Tens of thousands of breast cancer patients could safely go without radiation therapy after their tumor has been removed, a new study argues. Gene testing helped doctors identify a group of women who skipped radiation therapy because their cancer showed very low riskContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — Open-source automated insulin delivery (AID) systems are an effective and safe way for people with type 1 diabetes to control their blood sugar levels, researchers say. The AID systems combine an insulin pump, a continuous glucose monitor (CGM), and an algorithm that automaticallyContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be asContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimabContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Holocaust survivors have a lower risk of delirium after surgery than others their age, and a new study suggests it may owe to mental resilience developed in response to their horrific experiences. “Given that Holocaust survivors are at increased risk of a rangeContinue Reading